Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary Frances McMullin, Bridget S. Wilkins, Kate Ryan et al.|British Journal of Haematology|2005Cited by 339
A phase II study of vorinostat (<scp>MK</scp>‐0683) in patients with polycythaemia vera and essential thrombocythaemiaChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Mary Frances McMullin et al.|British Journal of Haematology|2013Cited by 71
Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostatChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Mads Emil Bjørn et al.|Leukemia Research|2014Cited by 13
A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential ThrombocythemiaChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Mary Frances McMullin et al.|Blood|2012Cited by 6
Circulating YKL-40 in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV) treated with the Novel Histone Deacetylase Inhibitor VorinostatChristen Lykkegaard Andersen, Hans Carl Hasselbalch, Vibe Skov et al.|University of Southern Denmark Research Portal (University of Southern Denmark)|2013Cited by 0